Behavioral and psychological symptoms of dementia (BPSD), also known as
neuropsychiatric symptoms, represent a heterogeneous group of non-cognitive symptoms …

There are an estimated 35 million people with dementia across the world, of whom 50%
experience regular pain. Despite this, current assessment and treatment of pain in this …

Prescription of medicines is a fundamental component of the care of elderly people, and
optimisation of drug prescribing for this group of patients has become an important public …

Objective To evaluate patterns of antipsychotic use. Design, setting, and measurements We
used nationally representative data from the IMS Health National Disease and Therapeutic …

Background Recently, the Food and Drug Administration (FDA) issued an advisory stating
that atypical antipsychotic medications increase mortality among elderly patients. However …

Objective To assess risks of mortality associated with use of individual antipsychotic drugs in
elderly residents in nursing homes. Design Population based cohort study with linked data …

Background: Public health advisories have warned that the use of atypical antipsychotic
medications increases the risk of death among elderly patients. We assessed the short-term …

The term polypharmacy has negative connotations due to its association with adverse drug
reactions and falls. This spectrum of adverse events widens when polypharmacy occurs …

BACKGROUND: Within the treatment of dementia, management of behavioural and
psychological symptoms (BPSD) is a complex component. PURPOSE: We wanted to offer a …

Background Recent reports documenting limited evidence supporting the use of
pharmacological interventions for neuropsychiatric symptoms (NPS) and increased risk of …